These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3457264

  • 21. Recombinant human interferon-alpha induced cytoreduction in chronic myelogenous leukemia. Results of a multicenter study.
    Werter M, de Witte R, Janssen J, de Pauw B, Haanen C.
    Blut; 1988 May; 56(5):209-12. PubMed ID: 3285912
    [Abstract] [Full Text] [Related]

  • 22. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D.
    Srp Arh Celok Lek; 2000 May; 128(7-8):262-70. PubMed ID: 11089434
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Recombinant alpha-2a interferon in treatment of B-chronic lymphocytic leukemia. A preliminary report with emphasis on previously untreated patients in early stage of disease.
    Molica S, Alberti A.
    Haematologica; 1990 May; 75(1):75-8. PubMed ID: 2338291
    [Abstract] [Full Text] [Related]

  • 25. Autologous transplantation for CML using marrow treated ex vivo with recombinant human interferon gamma.
    McGlave PB, Arthur D, Miller WJ, Lasky L, Kersey J.
    Bone Marrow Transplant; 1990 Aug; 6(2):115-20. PubMed ID: 2119838
    [Abstract] [Full Text] [Related]

  • 26. [Clinical studies of natural interferon alpha (HLBI) in chronic myelogenous leukemia--a multi-institutional cooperative study in Japan].
    Koyama S, Moriyama Y, Shibata A, Miura Y, Abe T, Asano S, Miyazaki T, Miura A, Kariyone S, Toyama K.
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2959-66. PubMed ID: 3052301
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients.
    Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU.
    Ann Intern Med; 1991 Apr 01; 114(7):532-8. PubMed ID: 2001086
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Low doses of interferon-alpha are as effective as higher doses in inducing remissions and prolonging survival in chronic myeloid leukemia.
    Schofield JR, Robinson WA, Murphy JR, Rovira DK.
    Ann Intern Med; 1994 Nov 15; 121(10):736-44. PubMed ID: 7944050
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group.
    Leventhal BG, Kashima HK, Mounts P, Thurmond L, Chapman S, Buckley S, Wold D.
    N Engl J Med; 1991 Aug 29; 325(9):613-7. PubMed ID: 1861694
    [Abstract] [Full Text] [Related]

  • 35. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service.
    Kantarjian HM, Smith TL, O'Brien S, Beran M, Pierce S, Talpaz M.
    Ann Intern Med; 1995 Feb 15; 122(4):254-61. PubMed ID: 7825760
    [Abstract] [Full Text] [Related]

  • 36. A trial of recombinant alpha 2 interferon in the myelodysplastic syndromes: I. Clinical results.
    Elias L, Hoffman R, Boswell S, Tensen L, Bonnem EM.
    Leukemia; 1987 Feb 15; 1(2):105-10. PubMed ID: 3478534
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2b.
    Niederle N, Kloke O, May D, Becher R, Osieka R, Schmidt CG.
    Invest New Drugs; 1987 Feb 15; 5 Suppl():S19-25. PubMed ID: 3474219
    [Abstract] [Full Text] [Related]

  • 40. Treatment of Ph'-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (Intron A).
    Alimena G, Morra E, Lazzarino M, Liberati AM, Montefusco E, Inveradi D, Bernasconi P, Mancini M, Grignani F, Bernasconi C.
    Cancer Treat Rev; 1988 Jan 15; 15 Suppl A():21-6. PubMed ID: 3277708
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.